Advertisement

Current Microbiology

, Volume 62, Issue 5, pp 1363–1367 | Cite as

Vancomycin-resistance Transferability from VanA Enterococci to Staphylococcus aureus

  • Simona de Niederhäusern
  • Moreno BondiEmail author
  • Patrizia Messi
  • Ramona Iseppi
  • Carla Sabia
  • Giuliano Manicardi
  • Immacolata Anacarso
Article

Abstract

In last decade methicillin-resistant Staphylococcus aureus with high level of vancomycin-resistance (VRSA) have been reported and generally the patients with VRSA infection were also infected with a vancomycin-resistant Enterococcus (VRE). Considering that the high level of vancomycin-resistance in VRSA isolates seems to involve the horizontal transfer of Tn1546 transposon containing vanA gene from coinfecting VRE strains, the authors have studied the “in vitro” conjugative transfer of this resistance from VanA enterococci to S. aureus. Out of 25 matings performed combining five vancomycin-resistant enterococci as donors (three Enterococcus faecalis and two Enterococcus faecium), and five S. aureus as recipients, all clinical isolates, two have been successful using E. faecalis as donor. The transfer of vancomycin-resistance was confirmed by vanA gene amplification in both transconjugants and the resistance was expressed at lower levels (MIC 32 μg/ml) in comparison with the respective VRE donors (MIC > 128 μg/ml). The vancomycin-resistance of trasconjugants was maintained even after subsequent overnight passages on MSA plates containing subinhibitory levels of vancomycin. This study shows that the vanA gene transfer can be achieved through techniques “in vitro” without the use of laboratory animals employed, in the only similar experiment previously carried out by other authors, as substrate for the trasconjugant growth. Moreover, in that previous experiment, contrary to this study, the vancomycin resistant S. aureus trasconjugants were selected on erythromycin agar and not by direct vancomycin agar selection.

Keywords

Minimum Inhibitory Concentration Vancomycin Vancomycin Resistance vanA Gene High Molecular Weight Plasmid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    CDC (2010) Reminds clinical laboratories and healthcare infection preventionists of their role in the search and containment of vancomycin-resistant Staphylococcus aureus (VRSA), May 2010Google Scholar
  2. 2.
    Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes F, Shah S, Rudrik JT, Pupp GR, Brown WJ, Cardo D, Fridkin SK (2003) Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 348:1342–1347PubMedCrossRefGoogle Scholar
  3. 3.
    Clinical and Laboratory Standards Institute (CLSI) (2008) Performance standards for antimicrobial susceptibility testing; 18th informational supplement M100–S18. CLSI, WayneGoogle Scholar
  4. 4.
    de Niederhäusern S, Sabia C, Messi P, Guerrieri E, Manicardi G, Bondi M (2004) Glycopeptide-resistance transferability from vancomycin-resistant enterococci of human and animal source to Listeria spp. Lett Appl Microbiol 39:483–489PubMedCrossRefGoogle Scholar
  5. 5.
    Dutka-Malen S, Evers S, Courvalin P (1995) Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 33:24–27PubMedGoogle Scholar
  6. 6.
    Liu C, Chambers HF (2003) Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother 47:3040–3045PubMedCrossRefGoogle Scholar
  7. 7.
    Macrina FL, Kopecko DJ, Jones KR, Ayers DJ, Mc Cowen SM (1978) A multiple plasmid-containing Escherichia coli strain: convenient source of size reference plasmid molecules. Plasmid 1:417–1420PubMedCrossRefGoogle Scholar
  8. 8.
    McGowan JE, Tenover FC (2004) Opinion-anti-infectives: confronting bacterial resistance in healthcare settings: a crucial role for microbiologists. Nat Rev Microbiol 2:251–258PubMedCrossRefGoogle Scholar
  9. 9.
    National Committee for Clinical Laboratory Standards (NCCLS) (2003) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, M7–A6, 6th edn. NCCLS, WayneGoogle Scholar
  10. 10.
    Noble WC, Virani Z, Cree RG (1992) Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 72:195–198PubMedCrossRefGoogle Scholar
  11. 11.
    O’Sullivan DJ, Klaenhammer R (1993) Rapid Mini-Prep isolation of high-quality plasmid DNA from Lactococcus and Lactobacillus spp. Appl Environ Microbiol 59:2730–2733PubMedGoogle Scholar
  12. 12.
    Périchon B, Courvalin P (2009) VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 53:4580–4587PubMedCrossRefGoogle Scholar
  13. 13.
    Raney PM, Williams PP, McGowan JE, Tenover FC (2002) Validation of Vitek version 7. 01 software for testing staphylococci against vancomycin. Diagn Microbiol Infect Dis 43:135–140PubMedCrossRefGoogle Scholar
  14. 14.
    Sabia C, de Niederhäusern S, Guerrieri E, Messi P, Anacarso I, Manicardi G, Bondi M (2007) Detection of bacteriocin production and virulence traits in vancomycin-resistant enterococci of different sources. J Appl Microbiol 104:970–979PubMedCrossRefGoogle Scholar
  15. 15.
    Saha B, Singh AK, Ghosh A, Ball M (2008) Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia). J Med Microbiol 57:72–79PubMedCrossRefGoogle Scholar
  16. 16.
    Severin A, Tabei K, Tenover F, Chung M, Clarke N, Tomasz A (2004) High level oxacillin and vancomycin resistance and altered cell wall composition in Staphylococcus aureus carrying the staphylococcal mecA and the enterococcal vanA gene complex. J Biol Chem 279:3398–3407PubMedCrossRefGoogle Scholar
  17. 17.
    Tenover FC, Weigel LM, Appelbaum PC et al (2004) Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother 48:275–280PubMedCrossRefGoogle Scholar
  18. 18.
    Weigel LM, Clewell Don B, Gill SR, Clark NC, McDougal LK, Flannagan SE, Kolonay JF, Shetty J, Killgore GE, Tenover FC (2003) Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302:1569–1571PubMedCrossRefGoogle Scholar
  19. 19.
    Zhu W, Clark NC, McDougal LK, Hageman J, McDonald LC, Patel JB (2008) Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-Like vanA plasmids in Michigan. Antimicrob Agents Chemother 52:452–457PubMedCrossRefGoogle Scholar
  20. 20.
    Zhu W, Murray PR, Huskins WC et al (2010) Dissemination of an Enterococcus Inc18-Like vanA plasmid associated with vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 54:4214–4320Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Simona de Niederhäusern
    • 1
  • Moreno Bondi
    • 1
    Email author
  • Patrizia Messi
    • 1
  • Ramona Iseppi
    • 1
  • Carla Sabia
    • 1
  • Giuliano Manicardi
    • 1
  • Immacolata Anacarso
    • 1
  1. 1.Department of Biomedical SciencesUniversity of Modena and Reggio EmiliaModenaItaly

Personalised recommendations